http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3766513-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e3b4f2ef8f062dcde3a2b7cd81748472
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b01dcd61775e996fac631d4b10c4e87f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43a72884e25aaecffebe0942132d704f
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
filingDate 2012-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfdf4443e5faec2014f57afa284ffb0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4740c8adba768069e8491651b88c85e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1055cffe7fe4035abb2ca923a9d18695
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33e662b4fca3061216083a2284f5fe2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ab99c61d6746278d690cba48297e972
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8f6ea339469d7a4841454983c50e378
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d42ad2fdda4f2ace6b4cef768e59c92
publicationDate 2021-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3766513-A1
titleOfInvention Use of low dosage il-2 for treating vasculitis
abstract The present invention relates to novel therapies for treating autoimmune and inflammatory diseases. More specifically, the present invention relates to a use of low dose interleukin-2 for the treatment of type I diabetes and other autoimmune and/or inflammatory diseases.
priorityDate 2011-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4530787-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0109748-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4748234-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4752585-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010049438-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4530787-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02078624-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4656132-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4604377-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0200280-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0136489-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0118617-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394420
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395848
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID37542
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406715
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406714
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21292785
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID232
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15764346
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24749

Total number of triples: 55.